Psychiatrist.com Home
Keyword Search
A Fresh Look at Monoamine Oxidase Inhibitors for Depression
Lawrence J. Cohen, PharmD, BCPP, FASHP, FCCP, FCP (Co-Chair), David A. Sclar, BPharm, PhD (Co-Chair), et al
When was the last time you thought about prescribing an MAOI to treat your patient with depression? If you're hesitant to use this class of medications or just need more information on these agents, read this Supplement to learn about the mechanism of action of MAOIs, review which foods and drugs may need to be avoided, and find out about a newer formulation that may minimize dietary restrictions and adverse events and can help to promote adherence.
4.5 Credits [See the entire activity]
Depression Epidemiology and Its Treatment Evolution
Robert M. A. Hirschfeld, MD
About 20% of US adults have a depressive episode at some point. Read this activity to review the prevalence and burden of depression and to understand how depression treatments came about.
0.5 Credit [See the entire activity]
MAOIs and Depression Treatment Guidelines
Michael E. Thase, MD
MAOIs were once a cornerstone of depression treatment and treatment guidelines still acknowledge their role. Here, find out what practice guidelines recommend—when to prescribe MAOIs and for whom.
0.5 Credit [See the entire activity]
An Update on MAOIs: Dietary Restrictions and Drug Interactions
David A. Flockhart, MD, PhD
In this Psychlopedia activity, review which foods should be avoided and which drugs are contraindicated with MAOIs. Then, find out about newer MAOIs that can lessen the need for dietary modifications and how personalizing treatment is the future of depression therapy.
0.5 Credit [See the entire activity]
MAOIs and Transdermal Delivery
Chad M. VanDenBerg, PharmD, BCPP
Dietary restrictions are a large part of why physicians are hesitant to prescribe MAOIs. Read this activity to find out about the mechanism of action of a newer MAOI formulation that may be easier to administer to certain patients with depression.
0.5 Credit [See the entire activity]
MAOIs: Issues in Treatment Adherence and Rates of Treatment Failure
Lawrence J. Cohen, PharmD, BCPP, FASHP, FCCP (Co-Chair), and David A. Sclar, BPharm, PhD (Co-Chair)
About a third of patients struggle to follow their treatment regimen. Here, discover strategies that are effective in improving patients' treatment adherence and learn about new MAOI formulations that can aid in that process.
0.5 Credit [See the entire activity]
The Use of MAOIs in Primary Care
Larry Culpepper, MD, MPH
Newer developments in antidepressant formulations may make MAOIs easier for PCPs to prescribe. Learn about the safety and efficacy of MAOIs and find out which of your patients may best respond to these agents.
0.5 Credit [See the entire activity]
